Atlas Trials

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Clinical trial NCT01036659 · UNKNOWN

Trial details

NCT number
NCT01036659
Sponsor
Bernstein, Jonathan A., M.D.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Angioedema
Start date
2010-05-01
Primary completion
2013-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.